Contravisory Investment Management, Inc. Gsk PLC Transaction History

Contravisory Investment Management, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 13, 2022	SELL	$42.05 - $47.77 $841 - $955	-20 Reduced 0.92%	2,165 $94,000
Q1 2022 Apr 08, 2022	BUY	$40.23 - $47.74 $87,902 - $104,311	2,185 New	2,185 $95,000
Q3 2020 Oct 08, 2020	SELL	$38.11 - $42.99 $68,559 - $77,339	-1,799 Closed	0 $0
Q2 2020 Jul 09, 2020	SELL	$37.87 - $43.58 $1,325 - $1,525	-35 Reduced 1.91%	1,799 $74,000
Q1 2020 Apr 09, 2020	BUY	$32.47 - $48.83 $17,241 - $25,928	531 Added 40.75%	1,834 $69,000
Q4 2019 Jan 09, 2020	SELL	$42.0 - $48.25 $756 - $868	-18 Reduced 1.36%	1,303 $61,000
Q3 2019 Oct 07, 2019	BUY	$40.46 - $43.52 $1,416 - $1,523	35 Added 2.72%	1,321 $56,000
Q4 2018 Jan 14, 2019	BUY	$37.8 - $42.69 $48,610 - $54,899	1,286 New	1,286 $49,000
Q1 2018 Apr 09, 2018	SELL	$36.18 - $40.15 $651 - $722	-18 Closed	0 $0
Q4 2017 Jan 18, 2018	BUY	$35.34 - $41.9 $636 - $754	18	18 $1,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.7B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Contravisory Investment Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Contravisory Investment Management, Inc. with notifications on news.